Drug Transporter Function—Implications in CKD-Reference-Cited by-同舟云学术

Drug Transporter Function—Implications in CKD

Published:2016-03 Issue:2 Volume:23 Page:76-81
ISSN:1548-5595
Container-title:Advances in Chronic Kidney Disease
language:en
Short-container-title:Advances in Chronic Kidney Disease

Author:

Schwenk Michael H.,Pai Amy Barton

Publisher

Elsevier BV

Subject

Nephrology

Reference39 articles.

1. Improving Global Outcomes (KDIGO) CKD Work Groups. KDIGO 2012 Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease;Kidney International. Suppl,2013

2. Ampicillin and cephalexin in renal insufficiency;Hori;Clin Pharmacol Ther,1983

3. A new dosing regimen in renal insufficiency: application to cephalexin;Hori;Clin Pharmacol Ther,1985

4. Drug transporters and Na+/H+ exchange regulatory factor PSD-95/Drosophila discs large/ZO-1 proteins;Walsh;Pharmacol Rev,2015

5. What do drug transporters really do?;Nigam;Nat Rev Drug Discov,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of X-ray irradiation on renal excretion of bestatin through down-regulating organic anion transporters via the vitamin D receptor in rats;Chemico-Biological Interactions;2024-08

2. Pharmacology of Tyrosine Kinase Inhibitors;Clinical Journal of the American Society of Nephrology;2023-12-11

3. Advanced Oxidation Protein Products Regulate the Pharmacokinetics of Aloe-emodin, Emodin, Rhein, and Chrysophanol in Chronic Kidney Disease Rats;Clinical Complementary Medicine and Pharmacology;2023-09

4. A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics;Environmental Health Perspectives;2023-07

5. Drug metabolism;Essentials of Medical Biochemistry;2023